Dow Up0.62% Nasdaq Up0.49%

More On COV.V



News & Info


Analyst Coverage

  • Analyst Opinion
  • Analyst Estimates


  • Major Holders
  • Insider Transactions
  • Insider Roster


Covalon Technologies Ltd. (COV.V)

1.74 Down 0.03(1.69%) 12:33PM EDT
ProfileGet Profile for:
Covalon Technologies Ltd.
405 Britannia Road East
Suite 106
Mississauga, ON L4Z 3E6
Canada - Map
Phone: 905-568-8400
Fax: 905-568-5200

Index Membership:N/A
Full Time Employees:N/A

Business Summary 

Covalon Technologies, Ltd. researches, develops, and commercializes healthcare technologies. It operates in two segments, Advanced Wound Care and Specialized Medical Device Coatings. The company offers medical coating platforms, including CovaCoat that provides photochemical process for covalently linking coating molecules to various medical device surfaces; and SilverCoat, an antimicrobial silicone foley catheter. Its medical coatings are used in infection control, therapeutic delivery, and lubricity. The company also offers process and manufacturing equipment validation assistance and on-site training services; and professional services, including feasibility studies, product formulation, prototype testing, validation, and manufacturing. In addition, it provides advanced wound care products comprising ColActive Plus Ag, an advanced wound care dressing; CovaGen, a bio-active wound contact layer dressing; CovaStat, a bio-active absorbable hemostatic sponge; and CovaSorb, a bio-active absorbent foam replacement dressing. Further, the company offers antimicrobial silicone dressings under the IV Clear and SurgiClear names for the vascular access and surgical wound care markets. It sells its technologies and products to medical companies and distributors worldwide. Covalon Technologies, Ltd. is headquartered in Mississauga, Canada.

Key Statistics

Company Websites 
Home Page
Search Yahoo! for:
More on Covalon Technologies Ltd.

Key Executives 
Mr. Abe Schwartz ,
Chairman and Advisor
Mr. Brian E. Pedlar ,
Chief Exec. Officer, Pres, Interim Chief Financial Officer and Director
Dr. Valerio DiTizio , 46
Co-Founder and Chief Science Officer
Kim Crooks ,
VP of Operations
Ms. Rosemary Siblall ,
Amounts are as of Dec 31, 2013 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
Currency in CAD.